(Q33741314)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10502742%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

review article

1 reference

title

The rational design of potential chemotherapeutic agents: synthesis of bryostatin analogues (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10502742%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference

ChEBI release 2020-05-28

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10502742%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

author name string

Wender PA

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10502742%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

Hinkle KW

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10502742%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

Lippa B

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10502742%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

publication date

1 September 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10502742%20AND%20SRC:MED&resulttype=core&format=json

Medicinal Research Reviews

31 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10502742%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10502742%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10502742%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

page(s)

388-407

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10502742%20AND%20SRC:MED&resulttype=core&format=json

A phase II study of bryostatin 1 in metastatic malignant melanoma

31 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-1128%28199909%2919%3A5%3C388%3A%3AAID-MED6%3E3.0.CO%3B2-H

A phase I trial of bryostatin 1 in patients with advanced malignancy using a 24 hour intravenous infusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-1128%28199909%2919%3A5%3C388%3A%3AAID-MED6%3E3.0.CO%3B2-H

A phase I study of intravenous bryostatin 1 in patients with advanced cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-1128%28199909%2919%3A5%3C388%3A%3AAID-MED6%3E3.0.CO%3B2-H

Bryostatin 1, a novel antineoplastic agent and protein kinase C activator, induces human myalgia and muscle metabolic defects: a 31P magnetic resonance spectroscopic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-1128%28199909%2919%3A5%3C388%3A%3AAID-MED6%3E3.0.CO%3B2-H

Modulation of bryostatin 1 muscle toxicity by nifedipine: effects on muscle metabolism and oxygen supply

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-1128%28199909%2919%3A5%3C388%3A%3AAID-MED6%3E3.0.CO%3B2-H

Tumor promotion by depleting cells of protein kinase C delta

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-1128%28199909%2919%3A5%3C388%3A%3AAID-MED6%3E3.0.CO%3B2-H

10.1002/(SICI)1098-1128(199909)19:5<388::AID-MED6>3.0.CO;2-H

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10502742%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference